TMO has broken through the 8, 13, and 21 daily exponential moving averages in the past few trading sessions. As a leader in laboratory diagnostics and life science sales distribution, it would seem reasonable that the stock may try to push higher as the coronavirus cases continue to grow. Now that the stock has pushed passed the 21 day EMA, there are no foreseeable areas of resistance for the stock and could make its way back up to recent highs nearing $530 per share. I would anticipate a slight pullback towards the 21 day EMA as stock rarely blast higher without some consolidation, but I would say that I am overall bullish on this stock until we reach previous highs.
REMEMBER: Reference to specific securities should not be construed as a recommendation to buy, sell or hold that security. Specific securities are mentioned for educational and informational purposes only. YouCanTrade is an online media publication service which provides investment educational content, ideas and demonstrations, and does not provide investment or trading advice, research or recommendations.
REMEMBER: Reference to specific securities should not be construed as a recommendation to buy, sell or hold that security. Specific securities are mentioned for educational and informational purposes only. YouCanTrade is an online media publication service which provides investment educational content, ideas and demonstrations, and does not provide investment or trading advice, research or recommendations.